Disease/Infection News

RSS

IRIN examines rise in new leprosy cases in remote region of Madagascar

IRIN examines an increase in new leprosy cases in Antalaha, a once-prosperous vanilla-exporting town in a remote region of Madagascar, where a 2009 military-supported coup brought the suspension of some foreign aid and trade benefits.

29 Sep 2011

Aborigines have higher STD rates than general Australian population

Aborigines in Australia have higher rates of sexually transmitted diseases such as gonorrhea, syphilis, and chlamydia than the country's general population, according to research by the University of New South Wales' Kirby Institute and reported on Tuesday at a sexual health conference, the Associated Press/Seattle Times reports.

29 Sep 2011

Cubist plans to move CB-183,315 into Phase 3 trial for treatment of CDAD

Cubist Pharmaceuticals, Inc. today announced it plans to move CB-183,315, being studied for the treatment of a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD, into late-stage trials.

29 Sep 2011

Thanks from Global Fund Executive Director Kazatchkine

The Global Fund to Fight AIDS, Tuberculosis and Malaria, "[a]long with our partners, both donors and implementers, is changing the story of scores of nations that were once devastated by three killer diseases -- diseases which seemed invincible," Global Fund Executive Director Michel Kazatchkine writes in a Huffington Post opinion piece, adding "we are now saving more than one million lives every year."

29 Sep 2011

African leaders showing 'clear commitment' to fighting malaria

"The focused attention that malaria has received by African governments and international organizations has had a major impact, with the rates of mortality coming down dramatically in the continent," and the African Leaders Malaria Alliance (ALMA) has helped lead this campaign, an IPP Media editorial states.

29 Sep 2011

Scientists report discovery of potential new drug for epidemic keratoconjunctivitis

Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.

29 Sep 2011

With ALMA scorecard, African leaders are taking responsibility in malaria fight

The African Leaders Malaria Alliance (ALMA) is "spearheading the fight against malaria" in Africa, bringing together 40 heads of state and "offering a compelling example of what is possible through co-operation, leadership, commitment, and sound management of national and international funds," Tanzania President Jakaya Mrisho Kikwete writes in a post on the Guardian's "Poverty Matters Blog."

29 Sep 2011

Researchers identify 'programmed cell death' pathway in parasitic worms

Researchers from the Walter and Eliza Hall Institute have for the first time identified a 'programmed cell death' pathway in parasitic worms that could one day lead to new treatments for one of the world's most serious and prevalent diseases.

29 Sep 2011

AASLD publishes updated practice guidelines on hepatitis C

On Monday, September 26, 2011, the American Association for the Study of Liver Diseases published online at its journal Hepatology's website an update to its practice guidelines for hepatitis C – "An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases."

29 Sep 2011

VOICE HIV prevention trial to discontinue use of tenofovir tablets

VOICE, an HIV prevention trial evaluating two antiretroviral (ARV)-based approaches for preventing the sexual transmission of HIV in women - daily use of one of two different ARV tablets or of a vaginal gel - will be dropping one of the oral tablets from the study.

29 Sep 2011

Post-Soviet economic breakdown may have contributed to re-emergence of NTDs in Central Asia

According to an article by Peter Hotez, president of the Sabin Vaccine Institute, and Ken Alibek of Nazarbayev University in Astana, Kazakhstan, published Tuesday in the journal PLoS Neglected Tropical Diseases, Central Asia "continues to suffer from a post-Soviet economic breakdown that may have contributed to a re-emergence of several NTDs in the area, especially among its most economically disadvantaged groups," a PLoS press release states.

29 Sep 2011

Viewpoints: Blocking, replacing health law; a doc's HPV advice; County wellness plan working

Too often, the Republican Party health-care agenda seems to consist of incanting "repeal and replace" and then to stop thinking-;if the thinking ever begins at all. Certainly the current Presidential field is saying little beyond promising to repeal ObamaCare, but in the nick of time Paul Ryan has provided some intellectual guidance in an important speech yesterday at Stanford's Hoover Institution. he said "we cannot simply revert to the status quo."

29 Sep 2011

Roche to sponsor 3rd Annual World MRSA Day

As part of its ongoing work in the prevention and control of serious infections in healthcare settings, Roche announced today its sponsorship of the 3rd Annual World MRSA Day.

From Roche Sequencing and Life Science 29 Sep 2011

Phase I clinical trials reveal MVA-B preventive vaccine's immune efficiency against HIV

Phase I clinical trials developed by Spanish Superior Scientific Research Council (CSIC) together with Gregorio Mara--n Hospital in Madrid and Cl-nic Hospital in Barcelona, reveals MVA-B preventive vaccine's immune efficiency against Human's immunodeficiency virus (HIV).

28 Sep 2011

Anthrax defenses need to be strengthened: Experts

It has been a decade since the anthrax attacks brought home the reality of bioterrorism and the nation now has a stockpile of some basic tools to fight back against a few of the threats that worry defense experts the most.

28 Sep 2011

'Urgent action' needed to prevent resistance to antiretroviral therapy

"The clear pattern of increasing antiretroviral resistance in lower-income settings must be considered in the context of the worldwide HIV-control agenda," especially because "the increasing rates of antiretroviral resistance in low-income settings represent a potential threat to the emerging treatment-as-prevention strategy," Evan Wood and Julio Montaner of the BC Centre for Excellence in HIV/AIDS write in a Lancet Infectious Diseases opinion piece.

28 Sep 2011

Scientists warn about climate-induced increase in death rates over the next 60 years

Scientists are warning that death rates linked to climate change will increase in several European countries over the next 60 yrs.

28 Sep 2011

Contaminated Cantaloupes carrying listeria leads to one of the worst outbreaks

According to federal health officials Tuesday, at least 13 people are dead amid 72 sickened in 18 states in an outbreak of listeria food poisoning tied to contaminated cantaloupes.

28 Sep 2011

Vietnam closes kindergartens to control outbreak of hand, foot and mouth disease

"More than a dozen kindergartens in Vietnam have closed to deal with an outbreak of hand, foot and mouth disease that has killed 111 children and sickened more than 57,000 this year, an official and the government said," according to the Associated Press/Washington Post.

28 Sep 2011

GAVI to purchase $1 billion in childhood vaccines for distribution in 37 of the poorest nations

The Geneva-based GAVI Alliance, a fund backed by governments, the World Bank, the WHO and the Bill & Melinda Gates Foundation, said in an e-mailed statement on Tuesday that it will purchase more than $1 billion in vaccines against rotavirus, pneumococcal and other diseases through deals made with GlaxoSmithKline, Pfizer Inc. and Merck & Co. to immunize children in 37 of the poorest nations, Bloomberg reports.

28 Sep 2011